{"id":728166,"date":"2026-06-10T19:53:09","date_gmt":"2026-06-10T19:53:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/728166\/"},"modified":"2026-06-10T19:53:09","modified_gmt":"2026-06-10T19:53:09","slug":"apotex-ipo-firm-ups-offering-to-sell-1-3-billion-in-shares","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/728166\/","title":{"rendered":"Apotex IPO: Firm ups offering to sell $1.3 billion in shares"},"content":{"rendered":"<p class=\"b-date-custom__date-item\">Updated:\u00a0June 10, 2026 at 2:27PM EDT<\/p>\n<p class=\"b-date-custom__date-item\">Published:\u00a0June 10, 2026 at 7:39AM EDT<\/p>\n<p>Jay Bala, CEO and senior portfolio manager at AIP Asset Management, joins BNN Bloomberg to discuss the Canadian markets. <\/p>\n<p class=\"c-paragraph\">Drug company Apotex Health Corp. has priced its initial public offering at $24 per share.<\/p>\n<p class=\"c-paragraph\">In its final prospectus, the company says it will issue 54,166,670 shares in the offering that is expected to see gross proceeds total $1.3 billion. That\u2019s more than an earlier plan by the company to sell $1 billion in shares.<\/p>\n<p class=\"c-paragraph\">Apotex says the offering includes a treasury offering of 35,416,666 shares for gross proceeds of $850 million and a secondary offering by certain shareholders of 18,750,004 shares for $450 million.<\/p>\n<p class=\"c-paragraph\">The selling shareholders have also granted the underwriters an over-allotment option for up to an additional 8,125,000 shares at the offer price.<\/p>\n<p class=\"c-paragraph\">The offering is expected to occur on or about June 16, subject to customary closing conditions. The shares traded for $27.05 in early afternoon trading on the Toronto Stock Exchange on an \u201cif, as and when issued\u201d basis Wednesday.<\/p>\n<p class=\"c-paragraph\">Apotex has a broad portfolio of generic drugs and consumer health products.<\/p>\n<p class=\"c-paragraph\">This report by The Canadian Press was first published June 10, 2026.<\/p>\n<p>Related Stories<\/p>\n","protected":false},"excerpt":{"rendered":"Updated:\u00a0June 10, 2026 at 2:27PM EDT Published:\u00a0June 10, 2026 at 7:39AM EDT Jay Bala, CEO and senior portfolio&hellip;\n","protected":false},"author":2,"featured_media":728167,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[45,49,48,23705],"class_list":["post-728166","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-ca","tag-canada","tag-pharma"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/728166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=728166"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/728166\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/728167"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=728166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=728166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=728166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}